| Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures Z Kan, Y Ding, J Kim, HH Jung, W Chung, S Lal, S Cho, ... Nature communications 9 (1), 1725, 2018 | 157 | 2018 |
| Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome YH Park, S Lal, JE Lee, YL Choi, J Wen, S Ram, Y Ding, SH Lee, E Powell, ... Nature communications 11 (1), 6175, 2020 | 129 | 2020 |
| Molecular signatures in breast cancer S Lal, AEMC Reed, XM de Luca, PT Simpson Methods 131, 135-146, 2017 | 80 | 2017 |
| Understanding the functional impact of copy number alterations in breast cancer using a network modeling approach S Srihari, M Kalimutho, S Lal, J Singla, D Patel, PT Simpson, KK Khanna, ... Molecular BioSystems 12 (3), 963-972, 2016 | 42 | 2016 |
| Breast cancer metastasis to gynaecological organs: a clinico‐pathological and molecular profiling study JR Kutasovic, AE McCart Reed, R Males, S Sim, JM Saunus, A Dalley, ... The Journal of Pathology: Clinical Research 5 (1), 25-39, 2019 | 38 | 2019 |
| LobSig is a multigene predictor of outcome in invasive lobular carcinoma AE McCart Reed, S Lal, JR Kutasovic, L Wockner, A Robertson, ... NPJ Breast Cancer 5 (1), 18, 2019 | 37 | 2019 |
| Stricturing Crohn’s disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions PK Mukherjee, QT Nguyen, J Li, S Zhao, SM Christensen, GA West, ... Gastroenterology 165 (5), 1180-1196, 2023 | 27 | 2023 |
| Personalised pathway analysis reveals association between DNA repair pathway dysregulation and chromosomal instability in sporadic breast cancer C Liu, S Srihari, S Lal, B Gautier, PT Simpson, KK Khanna, MA Ragan, ... Molecular oncology 10 (1), 179-193, 2016 | 26 | 2016 |
| Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer JM Saunus, XM De Luca, K Northwood, A Raghavendra, A Hasson, ... NPJ Breast Cancer 8 (1), 57, 2022 | 14 | 2022 |
| Epigenome erosion drives neural crest-like phenotypic mimicry in triple-negative breast cancer and other SOX10+ malignancies JM Saunus, XM De Luca, K Northwood, A Raghavendra, A Hasson, ... bioRxiv, 2021.03. 30.437624, 2021 | 2 | 2021 |
| Abstract PO3-15-09: LobSig4 is a superior and readily implementable ILC-focussed prognostic biomarker set L Kalinowski, J Kutasovic, S Srihari, Y Feng, S Lal, K Ferguson, ... Cancer Research 84 (9_Supplement), PO3-15-09-PO3-15-09, 2024 | | 2024 |
| Molecular signatures in breast cancer (vol 131, pg 135, 2017) S Lal, AEMC Reed, XM de Luca, PT Simpson METHODS 164, 120-120, 2019 | | 2019 |
| Evaluation of novel immunohistochemical biomarkers for invasive lobular carcinoma C Coorey, S Lal, J Kutasovic, C Niland, K Ferguson, LY Kuo, L Reid, ... Pathology 51, S77, 2019 | | 2019 |
| LobSig, a prognostic signature for Invasive Lobular Carcinoma AE McCart Reed, S Lal, JR Kutasovic, L Wockner, A Robertson, ... | | 2019 |
| Genomic and transcriptomic biomarkers of prognosis in invasive lobular breast cancer S Lal | | 2018 |
| Corrigendum to" Molecular signatures in breast cancer"[Methods 131 (2017) 135-146]. S Lal, MCR AE, XM de Luca, PT Simpson Methods (San Diego, Calif.) 164, 120-120, 2018 | | 2018 |
